User profiles for Stefano Romeo
Stefano Romeo, ProfessorUniversity of Gothenburg Verified email at wlab.gu.se Cited by 23020 |
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology
that varies in prevalence among ancestry groups. To identify genetic variants contributing …
that varies in prevalence among ancestry groups. To identify genetic variants contributing …
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Non-alcoholic fatty liver disease (NAFLD) is now recognised as the most common liver
disease worldwide. It encompasses a broad spectrum of conditions, from simple steatosis, …
disease worldwide. It encompasses a broad spectrum of conditions, from simple steatosis, …
[PDF][PDF] Leveraging human genetics to identify potential new treatments for fatty liver disease
Fatty liver disease (FLD), including its more severe pathologies, namely steatohepatitis,
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease worldwide …
hepatocarcinoma, and cirrhosis, is the most common cause of chronic liver disease worldwide …
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
…, K Raslova, P Siostrzonek, S Romeo… - European journal of …, 2021 - academic.oup.com
Aims To provide contemporary data on the implementation of European guideline
recommendations for lipid-lowering therapies (LLTs) across different settings and populations and …
recommendations for lipid-lowering therapies (LLTs) across different settings and populations and …
[HTML][HTML] Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
…, C Maglio, I Näslund, C Pirazzi, S Romeo… - … England Journal of …, 2012 - Mass Medical Soc
Background Weight loss protects against type 2 diabetes but is hard to maintain with behavioral
modification alone. In an analysis of data from a nonrandomized, prospective, controlled …
modification alone. In an analysis of data from a nonrandomized, prospective, controlled …
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
Background & Aims Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver
damage and is characterized by steatosis. Genetic factors increase risk for progressive NAFLD. …
damage and is characterized by steatosis. Genetic factors increase risk for progressive NAFLD. …
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL
S Romeo, LA Pennacchio, Y Fu, E Boerwinkle… - Nature …, 2007 - nature.com
Resequencing genes provides the opportunity to assess the full spectrum of variants that
influence complex traits. Here we report the first application of resequencing to a large …
influence complex traits. Here we report the first application of resequencing to a large …
[PDF][PDF] Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
…, S Fargion, L Sjöström, LM Carlsson, S Romeo… - …, 2015 - Wiley Online Library
Excess hepatic storage of triglycerides is considered a benign condition, but nonalcoholic
steatohepatitis (NASH) may progress to fibrosis and promote atherosclerosis. Carriers of the …
steatohepatitis (NASH) may progress to fibrosis and promote atherosclerosis. Carriers of the …
[HTML][HTML] Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans
The relative activity of lipoprotein lipase (LPL) in different tissues controls the partitioning of
lipoprotein-derived fatty acids between sites of fat storage (adipose tissue) and oxidation (…
lipoprotein-derived fatty acids between sites of fat storage (adipose tissue) and oxidation (…
Statin use and non-alcoholic steatohepatitis in at risk individuals
Background & Aims Excess hepatic free cholesterol contributes to the pathogenesis of non-alcoholic
steatohepatitis, and statins reduce cholesterol synthesis. Aim of this study was to …
steatohepatitis, and statins reduce cholesterol synthesis. Aim of this study was to …